PROK
NASDAQ · Biotechnology
Prokidney Corp
$1.14
+0.08 (+7.04%)
Open$1.05
Previous Close$1.07
Day High$1.16
Day Low$1.04
52W High$3.27
52W Low$1.30
Volume—
Avg Volume1.03M
Market Cap391.51M
P/E Ratio—
EPS$-0.55
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+1,638.6% upside
Current
$1.14
$1.14
Target
$19.82
$19.82
$13.43
$19.82 avg
$25.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.91M | 45.98M | 42.93M |
| Net Income | -147,172,655 | 9.61M | 10.78M |
| Profit Margin | -7,725.2% | 20.9% | 25.1% |
| EBITDA | -338,011,294 | 17.18M | 13.92M |
| Free Cash Flow | — | 13.69M | 9.06M |
| Rev Growth | — | +20.4% | +3.7% |
| Debt/Equity | 0.00 | 0.62 | 0.57 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |